PTIX

1.49

7.23% +0.1005

Vorhandelsmarkt: 1.36 -0.13 -8.72%

Protagenic Therapeutics Inc (PTIX)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$1.3895

Offen:

$1.3

24-Stunden-Volumen:

1,413

Marktkapitalisierung:

$6.61M

Einnahmen:

Nettoeinkommen (Verlust:

$-5.00M

KGV:

-1.8861

EPS:

-0.79

Netto-Cashflow:

$-3.85M

1W Leistung:

+15.50%

1M Leistung:

+10.37%

6M Leistung:

+83.95%

1J Leistung:

-24.37%

1-Tages-Spanne:

$1.30

$1.49

52-Wochen-Spanne:

$0.6797

$2.32

Protagenic Therapeutics Inc Stock (PTIX) Company Profile

Firmenname

Protagenic Therapeutics Inc

Sektor

Healthcare (1211)

Branche

Biotechnology (697)

Telefon

212 994 8200

Adresse

149 Fifth Avenue, Suite 500, New York

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-05-15

Neueste SEC-Einreichungen

PTIX's Discussions on Twitter

Protagenic Therapeutics Inc Aktie (PTIX) Neueste Nachrichten

Protagenic Therapeutics Completes Enrollment in Single Dose Portion of Phase 1 of Innovative Stress Disorder Trial - Yahoo Canada Finance

Yahoo Canada Finance

Likelihood of Approval and Phase Transition Success Rate Model - PT-00114 in Treatment Resistant Depression - GlobalData

GlobalData

Protagenic Therapeutics, Inc. (NASDAQ:PTIX) Q4 2023 Earnings Call Transcript - Yahoo Finance

Yahoo Finance

“We owe it to our ancestors and future generations to regroup and rebuild”, Dr. Garo Armen - CIVILNET - CivilNet English

CivilNet English

Protagenic Therapeutics Initiates Phase I/IIa Clinical Trial for Groundbreaking Brain Peptide PT00114 - Yahoo Finance

Yahoo Finance

Meta-analysis Finds Antidepressants Ineffective for Children and Adolescents - Mad in America

Mad in America

Finanzdaten der Protagenic Therapeutics Inc-Aktie (PTIX)